Sort
21,453 grants matching “tuberculosis”
Chemotherapeutics Against Multi-Drug Resistant Tuberculosis
$767,263Peter J Tonge · State University New York Stony Brook · U01 · FY2010 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$767,008Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Epidemiology of Mycobacterial Infections
$766,984Deborah Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Therapeutic drug monitoring for linezolid in the treatment of rifampin-resistant tuberculosis: a pragmatic randomized controlled trial
$766,877James C M Brust · Albert Einstein College Of Medicine · R01 · FY2025 · AI
AIDS Clinical Trial Group Laboratory Center
$766,819Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2025 · AI
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection
$766,391Amariliz Rivera · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Chemistry Core
$766,342Jeffrey Aube · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Macaque T cell signatures of Mtb control
$766,302Francois J Villinger · Emory University · U19 · FY2014 · AI
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$765,864Louise Sumner · Gryphon Scientific, Llc · N01 · FY2023 · AI
Modeling Core
$765,744Nitin S Baliga · Seattle Biomedical Research Institute · U19 · FY2015 · AI
Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in Brazil
$765,732Jonathan E Golub · Johns Hopkins University · R01 · FY2016 · AI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
$765,521Rasmus Skaarup Mortensen · Statens Serum Institute · R01 · FY2020 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$765,517Jon Tillinghast · Oklahoma State Department Of Health · U52 · FY2006 · PS
The Consequences of Reinfection with M. tuberculosis
$765,415Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$765,413Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection
$765,381John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2016 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome
$765,082Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Impact of TB coinfection on HIV reservoir
$764,755Kathryn M Dupnik · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Structural Genomics of Persistence Targets from M. tuberculosis
$764,514James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2008 · AI
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
$764,494William Robert Jacobs · Albert Einstein College Of Medicine · R24 · FY2023 · AI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
$764,417Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2016 · OD
Membrane Protein Structures and Interactions in the M. tuberculosis Divisome
$764,361Timothy A Cross · Florida State University · R01 · FY2015 · AI
Automated Sequencing for Culture-free Diagnosis of Drug Resistant TB
$764,235Timothy Charles Rodwell · University Of California, San Diego · R01 · FY2023 · AI
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$764,234Suresh K Mittal · Purdue University · R01 · FY2023 · AI
Treating Sleep Apnea in Type 2 Diabetes Mellitus: A Randomized Clinical Trial
$764,194Naresh Punjabi · Johns Hopkins University · R01 · FY2015 · HL